Key result
Dopamine-blocking agents cause neuroleptic malignant syndrome presenting with fever, rigidity, and dysautonomia requiring critical care.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Describes the characteristics and management of neuroleptic malignant syndrome in critical care contexts.
Neuroleptic malignant syndrome, characterized by fever, muscular rigidity, and dysautonomia, occurs with exposure to dopamine-blocking agents. Management, especially in critical care contexts, is described.
No takes yet. Share an insight, caveat, or question.
Wijdicks et al. (2024) studied this question. Exposure to dopamine-blocking agents causes neuroleptic malignant syndrome, which presents with fever, muscular rigidity, and dysautonomia and requires critical care management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: